Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Dec-22 9:16 AM View:  | Potter Stephen W Chief Business Officer | Applied Genetic Technologie... (AGTC) | 30-Nov-22 | Disposition | 8,750 | -- | -- | (16%) 55.88K to 47.13K | |
| 01-Dec-22 9:16 AM View: | Reynolds Gerald Anthony Chief Accounting Officer | Applied Genetic Technologie... (AGTC) | 30-Nov-22 | Disposition | 42,500 | -- | -- | (83%) 51.01K to 8.51K | |
| 01-Dec-22 9:16 AM View: | Potter Stephen W Chief Business Officer | Applied Genetic Technologie... (AGTC) | 30-Nov-22 | Disposition (change in control) | 47,133 | -- | -- | (100%) 47.13K to 0 | |
| 01-Dec-22 9:19 AM View: | Hurwitz Edward Director | Applied Genetic Technologie... (AGTC) | 30-Nov-22 | Disposition (change in control) | 25,672 | -- | -- | (93%) 27.47K to 1.8K | |
| 01-Dec-22 9:21 AM View: | Aliski William Director | Applied Genetic Technologie... (AGTC) | 30-Nov-22 | Disposition (change in control) | 8,500 | -- | -- | (100%) 8.5K to 0 | |
| 01-Dec-22 9:18 AM View: | Koenig Scott Director | Applied Genetic Technologie... (AGTC) | 30-Nov-22 | Disposition (change in control) | 34,246 | -- | -- | (100%) 34.25K to 0 | |
| 01-Dec-22 9:22 AM View: | Rosen James Director | Applied Genetic Technologie... (AGTC) | 30-Nov-22 | Disposition (change in control) | 1,000 | -- | -- | (100%) 1.0K to 0 | |
| 01-Dec-22 9:16 AM View: | Reynolds Gerald Anthony Chief Accounting Officer | Applied Genetic Technologie... (AGTC) | 30-Nov-22 | Disposition (change in control) | 8,506 | -- | -- | (100%) 8.51K to 0 | |
| 01-Dec-22 9:14 AM View: | Washer Susan B. President and CEO Director | Applied Genetic Technologie... (AGTC) | 30-Nov-22 | Disposition (change in control) | 143,021 | -- | -- | (100%) 143.02K to 0 | |
| 01-Dec-22 9:19 AM View: | Hurwitz Edward Director | Applied Genetic Technologie... (AGTC) | 30-Nov-22 | Disposition (change in control) | 1,800 | -- | -- | (100%) 1.8K to 0 | |
| 24-Aug-22 8:21 PM View: | Reynolds Gerald Anthony Chief Accounting Officer | Applied Genetic Technologie... (AGTC) | 21-Aug-22 | Grant | 30,000 | -- | -- | 143% 21.01K to 51.01K | |
| 01-Jul-22 4:01 PM View: | Potter Stephen W Chief Business Officer | Applied Genetic Technologie... (AGTC) | 01-Jul-22 | Sale | 8,070 | $0.77 | $6,250.22 | (13%) 63.95K to 55.88K | |
| 31-May-22 4:24 PM View: | Reynolds Gerald Anthony Chief Accounting Officer | Applied Genetic Technologie... (AGTC) | 27-May-22 | Sale | 3,994 | $0.85 | $3,375.73 | (16%) 25.0K to 21.01K | |
| 22-Feb-22 9:34 PM View: | Washer Susan B. President and CEO Director | Applied Genetic Technologie... (AGTC) | 18-Feb-22 | Option Sale | 9,950 | $2.18 | $21,691.00 | (7%) 152.97K to 143.02K | |
| 22-Feb-22 9:34 PM View: | Washer Susan B. President and CEO Director | Applied Genetic Technologie... (AGTC) | 18-Feb-22 | Option Exercise | 120,686 | $0.35 | $42,240.10 | 374% 32.28K to 152.97K | |
| 03-Nov-21 7:19 PM View: | Washer Susan B. President and CEO Director | Applied Genetic Technologie... (AGTC) | 01-Nov-21 | Option Exercise | 3,877 | $3.50 | $13,569.50 | 14% 28.41K to 32.28K | |
| 17-Aug-21 6:42 PM View: | Potter Stephen W Chief Business Officer | Applied Genetic Technologie... (AGTC) | 15-Aug-21 | Payment of Exercise | 5,724 | $3.58 | $20,491.90 | (8%) 69.68K to 63.95K | (7%) |
| 21-Jun-21 6:26 PM View: | Potter Stephen W Chief Business Officer | Applied Genetic Technologie... (AGTC) | 17-Jun-21 | Grant | 35,000 | -- | -- | 101% 34.68K to 69.68K | |
| 18-Aug-20 6:15 PM View: | Shearman Mark S Chief Scientific Officer | Applied Genetic Technologie... (AGTC) | 15-Aug-20 | Payment of Exercise | 5,723 | $5.77 | $33,021.70 | (15%) 39.0K to 33.28K | |
| 18-Aug-20 6:22 PM View: | Potter Stephen W VP and Chief Business Officer | Applied Genetic Technologie... (AGTC) | 15-Aug-20 | Payment of Exercise | 5,723 | $5.77 | $33,021.70 | (14%) 40.4K to 34.68K | |
| 30-Dec-19 4:33 PM View: | Krol Patrick Johan Hendrik 10% Owner | Applied Genetic Technologie... (AGTC) | 26-Dec-19 | Private Sale | 81,162 | $5.24 | $425,289.00 | (4%) 1.89M to 1.81M | |
| 26-Nov-19 5:17 PM View: | Krol Patrick Johan Hendrik 10% Owner | Applied Genetic Technologie... (AGTC) | 19-Nov-19 | Private Purchase | 2,544 | $2.79 | $7,097.76 | < 1% 1.88M to 1.89M | |
| 20-Sep-19 4:22 PM View: | Washer Susan B. President and CEO Director | Applied Genetic Technologie... (AGTC) | 18-Sep-19 | Option Exercise | 5,700 | $3.50 | $19,950.00 | 25% 22.71K to 28.41K | |
| 19-Aug-19 7:57 PM View: | Shearman Mark S Chief Scientific Officer | Applied Genetic Technologie... (AGTC) | 15-Aug-19 | Grant | 39,000 | -- | -- | 100% 0 to 39.0K | |
| 19-Aug-19 7:51 PM View: | Potter Stephen W VP and Chief Business Officer | Applied Genetic Technologie... (AGTC) | 15-Aug-19 | Grant | 39,000 | -- | -- | 2786% 1.4K to 40.4K | |
| 15-Jul-19 4:45 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 11-Jul-19 | Payment of Exercise | 592 | $3.75 | $2,220.00 | (1%) 56.64K to 56.05K | |
| 15-Jul-19 4:45 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 11-Jul-19 | Grant | 2,000 | -- | -- | 4% 54.64K to 56.64K | |
| 13-Jun-19 7:21 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 11-Jun-19 | Grant | 2,000 | -- | -- | 4% 53.33K to 55.33K | |
| 13-Jun-19 7:21 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 11-Jun-19 | Payment of Exercise | 685 | $3.77 | $2,582.45 | (1%) 55.33K to 54.64K | |
| 30-May-19 4:04 PM View: | Koenig Scott Director | Applied Genetic Technologie... (AGTC) | 28-May-19 | Option Exercise | 32,018 | $0.35 | $11,206.30 | 1437% 2.23K to 34.25K | |
| 15-May-19 4:21 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 13-May-19 | Payment of Exercise | 685 | $4.20 | $2,877.00 | (1%) 54.01K to 53.33K | |
| 15-May-19 4:21 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 13-May-19 | Grant | 2,000 | -- | -- | 4% 52.01K to 54.01K | |
| 15-Apr-19 5:42 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 11-Apr-19 | Payment of Exercise | 606 | $4.61 | $2,793.66 | (1%) 52.62K to 52.01K | |
| 15-Apr-19 5:42 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 11-Apr-19 | Grant | 2,000 | -- | -- | 4% 50.62K to 52.62K | |
| 13-Mar-19 5:16 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 11-Mar-19 | Grant | 2,000 | -- | -- | 4% 49.29K to 51.29K | |
| 13-Mar-19 5:16 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 11-Mar-19 | Payment of Exercise | 667 | $3.97 | $2,647.99 | (1%) 51.29K to 50.62K | |
| 13-Feb-19 6:30 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 11-Feb-19 | Payment of Exercise | 791 | $3.29 | $2,602.39 | (2%) 50.08K to 49.29K | < 1% |
| 13-Feb-19 6:30 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 11-Feb-19 | Grant | 2,000 | -- | -- | 4% 48.08K to 50.08K | |
| 15-Jan-19 7:58 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 11-Jan-19 | Payment of Exercise | 713 | $3.20 | $2,281.60 | (1%) 48.79K to 48.08K | (2%) |
| 15-Jan-19 7:58 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 11-Jan-19 | Grant | 2,000 | -- | -- | 4% 46.79K to 48.79K | |
| 18-Dec-18 7:36 PM View: | Washer Susan B. President and CEO Director | Applied Genetic Technologie... (AGTC) | 14-Dec-18 | Market Purchase | 2,380 | $3.34 | $7,949.20 | 12% 20.33K to 22.71K | (3%) |
| 18-Dec-18 8:10 PM View: | Sullivan William A. Chief Financial Officer | Applied Genetic Technologie... (AGTC) | 14-Dec-18 | Market Purchase | 3,000 | $3.33 | $9,990.00 | 100% 0 to 3.0K | (2%) |
| 18-Dec-18 7:58 PM View: | Shearman Mark S Chief Scientific Officer | Applied Genetic Technologie... (AGTC) | 14-Dec-18 | Market Sale | 3,000 | $3.35 | $10,052.70 | (100%) 3.0K to 0 | 3% |
| 18-Dec-18 8:20 PM View: | Aliski William Director | Applied Genetic Technologie... (AGTC) | 14-Dec-18 | Market Purchase | 6,000 | $3.25 | $19,477.00 | 240% 2.5K to 8.5K | < 1% |
| 18-Dec-18 8:29 PM View: | Rosen James Director | Applied Genetic Technologie... (AGTC) | 14-Dec-18 | Market Purchase | 1,000 | $3.38 | $3,381.00 | 100% 0 to 1.0K | (4%) |
| 13-Dec-18 9:23 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 11-Dec-18 | Payment of Exercise | 611 | $6.11 | $3,733.21 | (1%) 47.4K to 46.79K | 47% |
| 13-Dec-18 9:23 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 11-Dec-18 | Grant | 2,000 | -- | -- | 4% 45.4K to 47.4K | |
| 14-Nov-18 4:43 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 12-Nov-18 | Payment of Exercise | 685 | $7.05 | $4,829.25 | (1%) 46.09K to 45.4K | 54% |
| 14-Nov-18 4:43 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 12-Nov-18 | Grant | 2,000 | -- | -- | 5% 44.09K to 46.09K | |
| 15-Oct-18 7:01 PM View: | Feinsod Matthew Interim Chief Medical Officer | Applied Genetic Technologie... (AGTC) | 11-Oct-18 | Payment of Exercise | 612 | $6.46 | $3,953.52 | (1%) 44.7K to 44.09K | 50% |
